The technology used in the Raycome RBP-1200, to measure blood pressure, has passed in a clinical validation study, in a young population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||Recommended for children only||Validation in children|
|ESH (Europe)||Self-measurement for children||Published evidence|
|Stride BP||Office and hospital use for children (Preferred)||Published evidence|
|MDR Criteria||Self-measurement for children||Published evidence|
Dong J, Dong H, Ye P, Yan Y, Xi B, Mi J. Validation of the Raycome RBP-1200 upper-arm pulse wave device in children aged 3-12 years according to the Association for the Advancement of Medical Instrumentation protocol. Blood Press Monit. 2017 Feb;22(1):40-3. doi: 10.1097/MBP.0000000000000217. PMID: 27749333.
81060-2:2013 - Pass Children (n=87)